NOVEL TECHNOLOGIES FOR EVALUATION OF MOLECULAR ALTERATIONS INTISSUE - ADDENDUM

 

NIH GUIDE, Volume 26, Number 6, February 21, 1997

 

P.T. 34



Keywords:

  Cancer/Carcinogenesis 

  Biology, Cellular 

  Biology, Molecular 

  Gene Products 

  Genetic Manipulation 

 

National Cancer Institute

 

The following additional information is provided for RFA CA-97-011,

"Novel Technologies for Evaluation of Molecular Alterations in

Tissue," which appeared in the NIH Guide, Vol. 26, No. 2, January 17,

1997:

 

o  The National Cancer Institute (NCI) announces an increase in the

funds available to support applications received in response to RFA

CA-97-011.  The total funds available for the May 8, 1997 receipt

date will be $3.5 million.  The total funds available for the

November 13, 1997 receipt date will depend on the distribution of

funds from the FY 98 NCI budget.

 

The following information is provided in order to clarify the budget

limitations on R21 applications received in response to RFA

CA-97-011:

 

o  The maximum budget for the R21 applications is $100,000 direct

costs per year excluding indirect costs to collaborating

institutions.  Support can be requested for up to three years.  There

is no restriction on the budget of the R01 applications received in

response to this RFA.

 

INQUIRIES

 

For further information contact:

 

James W. Jacobson, Ph.D.

Division of Cancer Treatment, Diagnosis and Centers

National Cancer Institute

6130 Executive Boulevard, Room 513, MSC 7388

Bethesda, MD  20892-7388

Telephone:  (301) 496-0591

FAX:  (301) 402-1037

Email:  JJ37D@NIH.GOV

 

.

Return to 1997 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.